A Comparative Clinical Study of Herbal Drug in Memory Decline among patients of Type 2 Diabetes Mellitus

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2020
INTERVENTION: Intervention1: Saraswat Choorna: Dose‐ 1gm twice in a day Anupana‐ 5 ml Goghrita Route of administration ‐ Oral Duration of therepy ‐ 4 month Control Intervention1: Goghrita: Dose‐ 5ml twice in a day Anupana‐ Ushna Jala Route of administration ‐ Oral Duration of therepy ‐ 4 month CONDITION: Health Condition 1: F028‐ Dementia in other diseases classified elsewhere PRIMARY OUTCOME: Improvement in Cognitive Function on the basis of ACE III score and increase from baseline.Timepoint: 4 month duration of assessment of results SECONDARY OUTCOME: Improvement in SOD and MDA lab values and should improve from baselineTimepoint: 4 month duration of assessment of results INCLUSION CRITERIA: Patients age 35 ‐ 65 years and above of either sex, irrespective of work and socio economical status having memory complaint more than 6 months, whose score on ACE‐ III is 85‐92 whose minimal education is 7th standard and Onset of type II Diabetes mellitus for at least 5 years or more with controlled Blood Sugar Level parameters with No chronic inflammatory diseases or infections such as Rheumatoid Arthritis etc.and not on regular consumption of other herbal drugs and having Deterioration of memory along with at least three of the following five complaints: Poor orientation, Poor Judgment and Problem solving difficulties, Inability to function independently in home and during hobbies and difficulties in personal care.
Epistemonikos ID: 390686c14baeb719e7040122864c23094d30088a
First added on: Mar 24, 2022